Indian pharma industry facing growth headwinds: ICRA Industry-The Economic Times — December 8, 2016 comments off “In spite of these ongoing challenges, several Indian pharma companies are increasing their R&D spend, targeting pipeline of specialty drugs, niche molecules.”